Ad Vitam
- Thriller
- Drama
- Crime
- Action
When he and his pregnant wife are attacked in their home, a former elite agent becomes trapped in a deadly manhunt tied to his own painful past.
Ad Vitam is a French thriller starring Pierre Niney as a former elite agent whose pregnant wife is attacked in their home, thrusting him into a deadly manhunt connected to his dark past. Released on January 9, 2025, this crime-action drama combines intense personal stakes with high-octane suspense. The film explores themes of redemption and survival as the protagonist fights to protect his family while confronting the ghosts of his previous life.
When does Ad Vitam come out?
Where to watch
Streaming availability in United States
United States
Availability varies by country. A VPN can let you watch content licensed in another region, though most streaming services prohibit it in their terms of service. Use at your own discretion. Contains affiliate links.
Where to watch Ad Vitam by country
United Kingdom
Greece
Germany
France
Spain
Italy
Canada
Australia
BrazilTop cast
Follow an actor to track their next projects
Guillaume CanetFranck Lazareff
Alexis ManentiNico
Stéphane CaillardLeo
Nassim LyesBen
Zita HanrotManon
Johan HeldenberghVanaken
Etienne Guillou-KervernStanislas Lacaze
Jamel BlissatHomme DGSI 2
Maurice ChanLe policier scientifique- Laurent MerillonGendarme GIGN
- Marcel CanetAntoine (13 ans)
Trailer
Official Trailer [Subtitled]
Related & spin-offs
Other titles fans of Ad Vitam tend to follow.
Ad Vitam — frequently asked
When was Ad Vitam released?
Ad Vitam was released on January 9, 2025.
What is Ad Vitam about?
The film follows a former elite agent whose pregnant wife is attacked at home, forcing him into a deadly manhunt tied to his own painful past. He must navigate dangerous enemies while protecting his family and confronting his former life.
Where can I watch Ad Vitam?
Ad Vitam is available on Netflix.
Who stars in Ad Vitam?
Pierre Niney leads the cast as the former elite agent at the center of the story.
Comments(0)
No comments yet. Be the first.